Restricted access

The website you are trying to access is designed for healthcare professionals only - the content is not designed for the general public.

Are you a healthcare professional based in UK or Ireland?

YES
NO

This website is owned and managed by Viatris. For more information please visit viatris.co.uk

This site is intended for UK healthcare professionals only. Please click here to visit our public website.

Influvac® Tetra is indicated for the prophylaxis of influenza in adults and children from 6 months of age especially those who run an increased risk of associated complications. The use of Influenza vaccines should be based on official recommendations.

UK-INF-2024-00002 December 2024

© Copyright 2024 Viatris Inc. All rights reserved.

Viatris UK Healthcare Limited (company registration number 09189103), an English company with a registered office address at 20 Station Close, Potters Bar, Hertfordshire, EN6 1TL (VAT - 421 623 781)

Reporting of adverse reactions:

Adverse events and device failures should be reported

Please report suspected adverse drug reactions (ADRs) and device failures to the MHRA through the Yellow Card scheme. You can report via:

- the Yellow Card website www.mhra.gov.uk/yellowcard

- the free Yellow Card app available from the Apple App Store or Google Play Store

- some clinical IT systems (EMIS/SystmOne/Vision/MiDatabank) for healthcare professionals

Alternatively, you can report suspected adverse drug reactions and device failures to the Yellow Card scheme by calling 0800 731 6789 for free, Monday to Friday between 9am and 5pm. You can leave a message outside of these hours.

When reporting please provide as much information as possible. By reporting adverse drug reactions and device failures, you can help provide more information on the safety of this medicine.

You can also report directly to the manufacturer at pv.uk@viatris.com

Viatris logo